رفتن به محتوا

تداخل‌های دارویی

Nivolumab + Siponimod

شدت: متوسط

Nivolumab and Siponimod: moderate interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Nivolumab is a PD-1 checkpoint inhibitor that enhances immune activity and can cause immune-related adverse events, while siponimod sequesters lymphocytes. The combined effect is unpredictable, and corticosteroids used for immune toxicity would add to infection risk. Clinical data on the combination are lacking.

معنای این تداخل به زبان ساده

Nivolumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Nivolumab belongs to Oncology; Siponimod belongs to Central Nervous System.

سطح شواهد: Low

چرا رخ می‌دهد

Pharmacodynamic: opposing immune effects of S1P modulation and PD-1 blockade with unpredictable net result.

اقدام لازم

Weigh the need for both agents, and monitor lymphocyte counts and for infection and immune-related adverse events if combined.

از داروساز چه بپرسید

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Nivolumab و Siponimod، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۷ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Nivolumab with Siponimod?

MediHelp rates the interaction as moderate. Nivolumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nivolumab is a PD-1 checkpoint inhibitor that enhances immune activity and can cause immune-related adverse events, while siponimod sequesters lymphocytes. The combined effect is unpredictable, and corticosteroids used for immune toxicity would add to infection risk. Clinical data on the combination are lacking.

How serious is the interaction between Nivolumab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Weigh the need for both agents, and monitor lymphocyte counts and for infection and immune-related adverse events if combined.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود